Find editorial, opinion & Op-Ed articles from Brooks, Dowd, Friedman, Herbert, Kristof, Krugman, Safire & more. Read or e-mail a letter to the editor.: 100 Days: Report Cards on Trump
Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall CNBCPfizer Stock Rises After Earnings Beat. Trump Tariffs Uncertainty Remains. Barron'sPfizer misses revenue expectations, sees $1.7 billion more in cost savings ReutersPfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales with COVID infections in retreat MarketWatch